Genprex Statistics
Total Valuation
Genprex has a market cap or net worth of $9.80 million. The enterprise value is $1.93 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genprex has 9.21 million shares outstanding. The number of shares has increased by 1,063.89% in one year.
| Current Share Class | 9.21M |
| Shares Outstanding | 9.21M |
| Shares Change (YoY) | +1,063.89% |
| Shares Change (QoQ) | +177.21% |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | 0.73% |
| Float | 9.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 1.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.84
| Current Ratio | 3.84 |
| Quick Ratio | 3.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.97 |
Financial Efficiency
Return on equity (ROE) is -338.74% and return on invested capital (ROIC) is -202.41%.
| Return on Equity (ROE) | -338.74% |
| Return on Assets (ROA) | -135.78% |
| Return on Invested Capital (ROIC) | -202.41% |
| Return on Capital Employed (ROCE) | -194.32% |
| Weighted Average Cost of Capital (WACC) | 0.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.25M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.94% in the last 52 weeks. The beta is -0.67, so Genprex's price volatility has been lower than the market average.
| Beta (5Y) | -0.67 |
| 52-Week Price Change | -90.94% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 6.20 |
| Relative Strength Index (RSI) | 23.41 |
| Average Volume (20 Days) | 1,120,532 |
Short Selling Information
The latest short interest is 385,859, so 4.19% of the outstanding shares have been sold short.
| Short Interest | 385,859 |
| Short Previous Month | 479,992 |
| Short % of Shares Out | 4.19% |
| Short % of Float | 4.28% |
| Short Ratio (days to cover) | 1.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.52M |
| Pretax Income | -16.23M |
| Net Income | -16.23M |
| EBITDA | -15.51M |
| EBIT | -15.52M |
| Earnings Per Share (EPS) | -$17.40 |
Full Income StatementBalance Sheet
The company has $7.83 million in cash and n/a in debt, with a net cash position of $7.83 million or $0.85 per share.
| Cash & Cash Equivalents | 7.83M |
| Total Debt | n/a |
| Net Cash | 7.83M |
| Net Cash Per Share | $0.85 |
| Equity (Book Value) | 7.96M |
| Book Value Per Share | 2.42 |
| Working Capital | 6.18M |
Full Balance SheetCash Flow
| Operating Cash Flow | -15.31M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 6,693 |
| Net Borrowing | n/a |
| Free Cash Flow | -15.31M |
| FCF Per Share | -$1.66 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
